Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report

A Romero1, L Midaglia2, M T Salcedo3

  • 1Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Abstract